![](/img/cover-not-exists.png)
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption
Sabine D. Allard, Brenda De Keersmaecker, Anna L. de Goede, Esther J. Verschuren, Jeanette Koetsveld, Mariska L. Reedijk, Carolien Wylock, Annelies V. De Bel, Judith Vandeloo, Frank Pistoor, Carlo HeiVolume:
142
Year:
2012
Language:
english
Pages:
17
DOI:
10.1016/j.clim.2011.10.010
File:
PDF, 1.79 MB
english, 2012